Cargando…
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
Mitochondria serve as both “energy factories” and “suicide weapon stores” of cells. Targeted delivery of cytotoxic drugs to the mitochondria of tumor cells and tumor vascular cells is a promising strategy to improve the efficacy of chemotherapy. Here, multistage tumor-targeting liposomes containing...
Autores principales: | Sun, Jiawei, Jiang, Lei, Lin, Yi, Gerhard, Ethan Michael, Jiang, Xuehua, Li, Li, Yang, Jian, Gu, Zhongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338999/ https://www.ncbi.nlm.nih.gov/pubmed/28280323 http://dx.doi.org/10.2147/IJN.S122859 |
Ejemplares similares
-
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
por: Sheikh, Afsana, et al.
Publicado: (2022) -
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
por: Chen, Tianyu, et al.
Publicado: (2022) -
Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity
por: Hao, Wenjing, et al.
Publicado: (2019) -
Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells
por: Wen, Xianchun, et al.
Publicado: (2018) -
The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation
por: Zhang, Qi, et al.
Publicado: (2018)